DEFA14A: Masimo Postpones Annual Meeting, Files Lawsuit Against Politan Capital Over Proxy Misstatements

Masimo Corporation has postponed its 2024 Annual Meeting of Stockholders to September 19, 2024, and initiated litigation against Politan Capital Management LP for alleged material misstatements and omissions in their proxy materials.

Summary

• Masimo Corporation has postponed its 2024 Annual Meeting of Stockholders, originally scheduled for July 25, 2024, to September 19, 2024.
• The company has filed a lawsuit against Politan Capital Management LP, alleging material misstatements and omissions in Politan's proxy materials.
• The postponement was partly to accommodate a request by Politan to set a new record date for the meeting.
• The new record date for determining stockholders eligible to vote at the Annual Meeting is August 12, 2024.
• Masimo will file a revised proxy statement with the SEC to reflect the rescheduled meeting date, the new record date, and information relating to the shares outstanding as of the record date.
• All previously submitted votes will be disregarded, and stockholders will need to resubmit their votes after reviewing the revised proxy materials.
• Stockholders who wish to have a proposal considered for inclusion in the company's proxy materials must submit it by July 26, 2024.
• Stockholders who wish to bring business before the 2024 Annual Meeting outside of Rule 14a-8 of the Exchange Act or to nominate a person for election as a director must ensure that written notice of such proposal is received by Masimos Corporate Secretary no later than the close of business on July 26, 2024.

Sentiment

Score: 4

Explanation: The announcement includes both positive (company defending itself against perceived misstatements) and negative (postponement, litigation) elements, resulting in a slightly negative sentiment.

Positives

• Masimo is ensuring stockholders have sufficient time to review revised proxy materials and make informed voting decisions.
• The company is taking action to address what it believes are misstatements in Politan's proxy materials.

Negatives

• The postponement of the Annual Meeting introduces uncertainty and potential delays.
• The litigation with Politan could be costly and distracting for management.
• All stockholders must resubmit their votes, which could cause confusion or apathy.

Risks

• Uncertainties regarding the litigation with Politan.
• Potential future actions by Politan in furtherance of its nomination of director candidates.
• The potential cost and management distraction attendant to Politan's nomination of director nominees or the litigation.
• Receipt of any new or additional stockholder proposals for consideration at the 2024 Annual Meeting.

Future Outlook

Masimo will file a revised proxy statement and mail a new notice of the Annual Meeting and proxy card to all stockholders entitled to vote as of the new record date.

Industry Context

The proxy fight between Masimo and Politan reflects a broader trend of increased shareholder activism, particularly in the healthcare sector, where companies are facing pressure to improve performance and governance.

Legal Proceedings

• Masimo has commenced litigation against Politan Capital Management LP in federal court in California.

Stakeholder Impact

• Shareholders will need to resubmit their votes and review revised proxy materials.
• The litigation and proxy fight could impact employee morale and productivity.
• The outcome of the proxy fight could influence the company's strategic direction and performance.

Next Steps

• Masimo will file a revised proxy statement with the SEC.
• Masimo will mail a new notice of the Annual Meeting and proxy card to all stockholders.
• Stockholders will need to resubmit their votes.
• The company will continue with litigation against Politan Capital Management.

Key Dates

Keywords

Masimo, Politan Capital Management, Annual Meeting, Proxy Statement, Litigation, Stockholders, SEC, Director Nominations, Record Date, Proxy Materials